GlucoTrack, Inc. (GCTK)

CIK 0001506983 · Healthcare · Medical Instruments & Supplies

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 8-K (2026-05-14) · 99.1
Latest FY-2025 8-K (2026-03-30) · 99.1
Q3-2025 8-K (2025-11-13) · 99.1
Q2-2025 8-K (2025-08-14) · 99.1
Q1-2025 8-K (2025-05-14) · 99.1
FY-2024 8-K (2025-03-31) · 99.1
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations and Comprehensive Loss
Condensed Consolidated Statement of Changes In Stockholders' Equity (deficit) (unaudited)
—
Consolidated Statements of Changes In Stockholders' (deficit) Equity
—
Consolidated Statements of Changes In Stockholders' Equity
Condensed Consolidated Statement of Changes In Stockholders' Equity (unaudited) (P)
—
Consolidated Statements of Cash Flows
Consolidated Statements of Changes In Stockholders' (deficit) Equity (P)
—
Consolidated Statements of Cash Flows (P)
—
Notes
Commitments and Contingent Liabilities
Common Stock and Warrants With-down Round Protection
—
Cybersecurity Risk Management and Strategy Disclosure
—
Finance (income) Expenses, Net
General
General and Administrative Expenses
—
Income Tax
—
Income Taxes
—
Insider Trading Arrangements
—
Insider Trading Policies and Procedures
—
Lease Agreement
—
Loans From Stockholders
—
Organization and Business
Pay Vs Performance Disclosure
—
Related Parties
—
Research and Development Expenses
—
Segment Reporting
—
Share-based Compensation
—
Significant Transactions
Subsequent Events
Summary of Significant Accounting Policies